Venture Capital


Join Me at BIO-Europe Spring Mar. 21 in Barcelona To Talk EU Entrepreneurship

I’ve never been to Barcelona, but they say nice things about the place. Frankly, I don’t know much about biotech startup culture there, but I intend to sponge up as much as I can about tech transfer, company creation, and some of the particular hornet nests that European entrepreneurs have to work through to create value in healthcare. Regular readers...
Read More

Pfizer, GSK, AbbVie Join $51.5M Bet on Computational Drug Discovery Shop, Morphic Therapeutic

Integrins were a big deal in the early days of biotech in the 1980s and 1990s. They looked like a promising class of receptors found on cells implicated in many diseases. Billion-dollar dreams were in the air. Then, thunderstruck by dangerous and surprising side effects, integrin-directed drugs were tossed in the trash. But integrin biology is making a comeback with...
Read More